advertisement
Araie M 16
Showing records 1 to 16 | Display all abstracts from Araie M112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Araie M
Advances in Therapy 2023; 40: 4639-4656
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Sakata R
Eye 2024; 38: 737-744
112075 Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes
Saito H; Ueta T
American Journal of Ophthalmology 2024; 257: 91-102
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Araie M
Eye 2024; 38: 737-744
112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Sugiyama K
Advances in Therapy 2023; 40: 4639-4656
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Yoshitomi T
Eye 2024; 38: 737-744
112075 Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes
Araie M
American Journal of Ophthalmology 2024; 257: 91-102
112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Aso K
Advances in Therapy 2023; 40: 4639-4656
112075 Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes
Enomoto N
American Journal of Ophthalmology 2024; 257: 91-102
112890 Factors associated with visual field or structure progression occurring first in a prospective study on patients with untreated open-angle glaucoma with normal intraocular pressure
Eye 2024; 38: 737-744
112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Kanemoto K; Iwata R
Advances in Therapy 2023; 40: 4639-4656
112075 Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes
Kambayashi M
American Journal of Ophthalmology 2024; 257: 91-102
112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Hollander DA
Advances in Therapy 2023; 40: 4639-4656
112075 Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes
Murata H; Kikawa T
American Journal of Ophthalmology 2024; 257: 91-102
112397 Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
Senchyna M; Kopczynski CC
Advances in Therapy 2023; 40: 4639-4656
112075 Association of Bergmeister Papilla and Deep Optic Nerve Head Structures With Prelaminar Schisis of Normal and Glaucomatous Eyes
Sugiyama K; Higashide T; Miki A; Iwase A; Tomita G; Nakazawa T; Aihara M; Ohno-Matsui K; Kim TW; Leung CKS; Zangwill LM; Weinreb RN
American Journal of Ophthalmology 2024; 257: 91-102
